Explores the genetic mechanisms of retinoblastoma and their clinical implications, shedding light on tumor suppression, DNA repair, and genetic recombination.
Explores personalized medicine, genetic variability, and drug response, emphasizing tailoring treatments based on individual genetic and metabolic profiles.
